Bias among Statins Drug Trials
People of all ages as well as elderly have been bamboozled into taking cholesterol-lowering drugs (statins) to prevent heart disease.
All statin drug trials from 1990 to 1999 suffered from age and gender bias. The statin drug trials were mainly conducted using middle-aged men, and did not study the effects among women, children, and the elderly or ethnic groups. Among these studies were 4S, CARE, LIPID, EXCEL, REGRESS, PREDICT, ACAPS, AFCAPS, WOSCOP, KAPS. There were 19 studies in total.
The General Accounting Office (GAO) of the United States Government has recognized the bias and stated:
"The trials generally have not evaluated the efficacy of cholesterol-lowering treatment for several important population groups, such as women, elderly men and women, and minority men and women. Thus, they provide little or no evidence of benefits or possible risks for these groups."
This is not medical advice. Medical diagnosis and treatment is constrained by law to be the monopoly of state licensed practitioners.
Life-Saving Health Briefs By Shane Ellison, M.Sc. at Ref [2]
Author Health Myths Exposed and Hidden Truth about Cholesterol-Lowering Drugs.
